WHO ICTRP trial

A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of…

CTIS2024-511561-10-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2024-511561-10-00
Public title A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head and Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)
Scientific title A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head and Neck (SCCHN), or Metastatic Urothelial Bladder…
Primary sponsor Io Biotech ApS
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries United States;United Kingdom;Spain
Conditions Metastatic Urothelial Bladder Cancer (mUBC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) MedDRA version: 21.0Level: LLTClassification code: 10046722Term: Urothelial carcinoma…
Interventions Product Name: IO102-IO103, Product Code:PRD9294901, Pharmaceutical Form: LYOPHILIZED POWDER FOR PREPARATION FOR INJECTION (8), Other descriptive name: , Strength: , Product Name: KEYTRUDA 25 mg/mL concentrate for solution for infusion…
Registration date Sep 2, 2024
Target size 90
Secondary IDs 2021-003026-69
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations